Frequencies for first 10,000 rows of indi_pt variable in indi2016q2 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- 21-hydroxylase deficiency | 2 0.02 0.02 Abdominal discomfort | 7 0.07 0.09 Abdominal distension | 1 0.01 0.10 Abdominal hernia | 3 0.03 0.13 Abdominal pain | 7 0.07 0.20 Abdominal pain upper | 10 0.10 0.30 Abortion induced | 2 0.02 0.32 Accidental exposure to product | 1 0.01 0.33 Acne | 8 0.08 0.41 Acne cystic | 5 0.05 0.46 Acral overgrowth | 4 0.04 0.50 Acromegaly | 27 0.27 0.77 Activities of daily living impaired | 1 0.01 0.78 Acute coronary syndrome | 14 0.14 0.92 Acute disseminated encephalomyelitis | 5 0.05 0.97 Acute kidney injury | 1 0.01 0.98 Acute lymphocytic leukaemia | 10 0.10 1.08 Acute lymphocytic leukaemia recurrent | 3 0.03 1.11 Acute myeloid leukaemia | 11 0.11 1.22 Acute myocardial infarction | 3 0.03 1.25 Acute pulmonary oedema | 1 0.01 1.26 Addison's disease | 2 0.02 1.28 Adenocarcinoma of colon | 1 0.01 1.29 Adjuvant therapy | 5 0.05 1.34 Adrenal gland cancer | 4 0.04 1.38 Adrenal insufficiency | 1 0.01 1.39 Adrenocortical steroid therapy | 1 0.01 1.40 Adrenocorticotropic hormone deficiency | 1 0.01 1.41 Adrenogenital syndrome | 2 0.02 1.43 Adult T-cell lymphoma/leukaemia | 1 0.01 1.44 Adverse event | 1 0.01 1.45 Affective disorder | 9 0.09 1.54 Afterbirth pain | 3 0.03 1.57 Age-related macular degeneration | 6 0.06 1.63 Aggression | 2 0.02 1.65 Agitation | 5 0.05 1.70 Alanine aminotransferase increased | 1 0.01 1.71 Alcohol use | 1 0.01 1.72 Allergy prophylaxis | 4 0.04 1.76 Alopecia | 54 0.54 2.30 Alopecia areata | 2 0.02 2.32 Alveolar soft part sarcoma | 1 0.01 2.33 Amenorrhoea | 1 0.01 2.34 Anaemia | 16 0.16 2.50 Anaesthesia reversal | 1 0.01 2.51 Anaesthetic complication vascular | 1 0.01 2.52 Analgesic therapy | 21 0.21 2.73 Anaplastic astrocytoma | 7 0.07 2.80 Androgen replacement therapy | 1 0.01 2.81 Androgenetic alopecia | 99 0.99 3.80 Angina pectoris | 23 0.23 4.03 Angiomyolipoma | 2 0.02 4.05 Ankylosing spondylitis | 35 0.35 4.40 Antacid therapy | 1 0.01 4.41 Anti-neutrophil cytoplasmic antibody .. | 1 0.01 4.42 Antiallergic therapy | 2 0.02 4.44 Antibiotic prophylaxis | 5 0.05 4.49 Antibiotic therapy | 2 0.02 4.51 Anticoagulant therapy | 25 0.25 4.76 Antidepressant therapy | 6 0.06 4.82 Antiemetic supportive care | 7 0.07 4.89 Antifungal prophylaxis | 8 0.08 4.97 Antiinflammatory therapy | 1 0.01 4.98 Antiplatelet therapy | 1 0.01 4.99 Antiviral prophylaxis | 4 0.04 5.03 Anxiety | 89 0.89 5.92 Anxiety disorder | 1 0.01 5.93 Anxiolytic therapy | 1 0.01 5.94 Aortic valve incompetence | 1 0.01 5.95 Aortic valve replacement | 1 0.01 5.96 Aplastic anaemia | 17 0.17 6.13 Appetite disorder | 1 0.01 6.14 Arrhythmia | 5 0.05 6.19 Arterial disorder | 1 0.01 6.20 Arteriosclerosis | 8 0.08 6.28 Arteritis | 1 0.01 6.29 Arthralgia | 24 0.24 6.53 Arthritis | 27 0.27 6.80 Arthritis infective | 1 0.01 6.81 Arthritis reactive | 1 0.01 6.82 Arthropathy | 3 0.03 6.85 Artificial menopause | 1 0.01 6.86 Ascites | 2 0.02 6.88 Aspartate aminotransferase increased | 1 0.01 6.89 Aspergillus infection | 2 0.02 6.91 Asthenia | 3 0.03 6.94 Asthma | 185 1.85 8.79 Asthma exercise induced | 3 0.03 8.82 Asthma prophylaxis | 4 0.04 8.86 Astrocytoma, low grade | 3 0.03 8.89 Atherosclerosis prophylaxis | 1 0.01 8.90 Atrial fibrillation | 66 0.66 9.56 Atrophic vulvovaginitis | 1 0.01 9.57 Attention deficit/hyperactivity disor.. | 28 0.28 9.85 Atypical mycobacterial infection | 1 0.01 9.86 Autism | 2 0.02 9.88 Autism spectrum disorder | 2 0.02 9.90 Autoimmune haemolytic anaemia | 1 0.01 9.91 Autonomic neuropathy | 1 0.01 9.92 Axial spondyloarthritis | 2 0.02 9.94 B-cell lymphoma | 28 0.28 10.22 B-cell small lymphocytic lymphoma | 2 0.02 10.24 Back disorder | 5 0.05 10.29 Back pain | 30 0.30 10.59 Bacteraemia | 1 0.01 10.60 Bacterial infection | 2 0.02 10.62 Barrett's oesophagus | 15 0.15 10.77 Basal cell carcinoma | 1 0.01 10.78 Behcet's syndrome | 10 0.10 10.88 Benign prostatic hyperplasia | 21 0.21 11.09 Benign rolandic epilepsy | 1 0.01 11.10 Biliary cancer metastatic | 3 0.03 11.13 Bipolar I disorder | 7 0.07 11.20 Bipolar disorder | 80 0.80 12.00 Bladder cancer | 5 0.05 12.05 Bladder disorder | 2 0.02 12.07 Blindness | 1 0.01 12.08 Blood calcium | 1 0.01 12.09 Blood calcium decreased | 2 0.02 12.11 Blood cholesterol | 5 0.05 12.16 Blood cholesterol abnormal | 41 0.41 12.57 Blood cholesterol increased | 76 0.76 13.33 Blood disorder | 5 0.05 13.38 Blood glucose abnormal | 3 0.03 13.41 Blood glucose increased | 1 0.01 13.42 Blood immunoglobulin E increased | 1 0.01 13.43 Blood iron abnormal | 1 0.01 13.44 Blood iron decreased | 2 0.02 13.46 Blood oestrogen decreased | 1 0.01 13.47 Blood potassium decreased | 1 0.01 13.48 Blood pressure abnormal | 38 0.38 13.86 Blood pressure decreased | 1 0.01 13.87 Blood pressure increased | 3 0.03 13.90 Blood pressure management | 2 0.02 13.92 Blood pressure measurement | 22 0.22 14.14 Blood prolactin increased | 2 0.02 14.16 Blood testosterone decreased | 2 0.02 14.18 Blood thyroid stimulating hormone dec.. | 1 0.01 14.19 Blood triglycerides abnormal | 3 0.03 14.22 Blood triglycerides increased | 2 0.02 14.24 Body height below normal | 1 0.01 14.25 Body tinea | 1 0.01 14.26 Bone cancer | 5 0.05 14.31 Bone density decreased | 4 0.04 14.35 Bone disorder | 14 0.14 14.49 Bone loss | 2 0.02 14.51 Bone marrow conditioning regimen | 5 0.05 14.56 Bone pain | 2 0.02 14.58 Brachial plexopathy | 1 0.01 14.59 Brain injury | 5 0.05 14.64 Brain neoplasm | 4 0.04 14.68 Brain neoplasm benign | 1 0.01 14.69 Brain oedema | 3 0.03 14.72 Brain stem glioma | 2 0.02 14.74 Breakthrough pain | 1 0.01 14.75 Breast cancer | 73 0.73 15.48 Breast cancer female | 5 0.05 15.53 Breast cancer metastatic | 28 0.28 15.81 Breast cancer stage III | 3 0.03 15.84 Bronchitis | 17 0.17 16.01 Bronchitis chronic | 3 0.03 16.04 Bronchopulmonary aspergillosis | 2 0.02 16.06 Burkitt's lymphoma stage IV | 1 0.01 16.07 Burning sensation | 3 0.03 16.10 Cancer pain | 1 0.01 16.11 Carcinoid syndrome | 3 0.03 16.14 Carcinoid tumour | 5 0.05 16.19 Cardiac disorder | 55 0.55 16.74 Cardiac failure | 220 2.20 18.94 Cardiac failure chronic | 58 0.58 19.52 Cardiac failure congestive | 33 0.33 19.85 Cardiovascular disorder | 5 0.05 19.90 Cardiovascular event prophylaxis | 14 0.14 20.04 Carotid artery occlusion | 3 0.03 20.07 Castleman's disease | 3 0.03 20.10 Cataract | 2 0.02 20.12 Cataract nuclear | 2 0.02 20.14 Cataract subcapsular | 1 0.01 20.15 Central nervous system lesion | 3 0.03 20.18 Central pain syndrome | 7 0.07 20.25 Cerebral artery embolism | 5 0.05 20.30 Cerebral artery occlusion | 1 0.01 20.31 Cerebral disorder | 4 0.04 20.35 Cerebral infarction | 1 0.01 20.36 Cerebral ischaemia | 1 0.01 20.37 Cerebrovascular accident | 4 0.04 20.41 Cerebrovascular accident prophylaxis | 23 0.23 20.64 Cerebrovascular disorder | 3 0.03 20.67 Cervix carcinoma | 1 0.01 20.68 Chemotherapy | 30 0.30 20.98 Chest pain | 5 0.05 21.03 Chills | 5 0.05 21.08 Chlamydial infection | 1 0.01 21.09 Choking | 4 0.04 21.13 Cholangiocarcinoma | 1 0.01 21.14 Cholangitis sclerosing | 1 0.01 21.15 Cholecystitis | 3 0.03 21.18 Choroidal neovascularisation | 1 0.01 21.19 Chronic gastritis | 2 0.02 21.21 Chronic graft versus host disease | 2 0.02 21.23 Chronic hepatitis B | 2 0.02 21.25 Chronic hepatitis C | 49 0.49 21.74 Chronic inflammatory demyelinating po.. | 1 0.01 21.75 Chronic lymphocytic leukaemia | 25 0.25 22.00 Chronic myeloid leukaemia | 45 0.45 22.45 Chronic myelomonocytic leukaemia | 3 0.03 22.48 Chronic obstructive pulmonary disease | 89 0.89 23.37 Chronic sinusitis | 2 0.02 23.39 Chronic spontaneous urticaria | 1 0.01 23.40 Clavicle fracture | 1 0.01 23.41 Coccidioidomycosis | 1 0.01 23.42 Colitis | 9 0.09 23.51 Colitis ulcerative | 131 1.31 24.82 Colon cancer | 32 0.32 25.14 Colon cancer metastatic | 1 0.01 25.15 Colon cancer recurrent | 4 0.04 25.19 Colony stimulating factor therapy | 1 0.01 25.20 Colorectal cancer | 21 0.21 25.41 Colorectal cancer metastatic | 11 0.11 25.52 Coma | 2 0.02 25.54 Completed suicide | 2 0.02 25.56 Complex partial seizures | 4 0.04 25.60 Complex regional pain syndrome | 3 0.03 25.63 Confusional state | 1 0.01 25.64 Conjunctivitis | 5 0.05 25.69 Connective tissue disorder | 1 0.01 25.70 Constipation | 36 0.36 26.06 Constipation prophylaxis | 4 0.04 26.10 Contraception | 22 0.22 26.32 Convulsion prophylaxis | 1 0.01 26.33 Cor pulmonale chronic | 1 0.01 26.34 Coronary arterial stent insertion | 2 0.02 26.36 Coronary artery bypass | 2 0.02 26.38 Coronary artery disease | 10 0.10 26.48 Cough | 7 0.07 26.55 Crohn's disease | 91 0.91 27.46 Cryoglobulinaemia | 1 0.01 27.47 Cystic fibrosis | 9 0.09 27.56 Cystitis | 1 0.01 27.57 Cystitis ulcerative | 4 0.04 27.61 Cystoid macular oedema | 2 0.02 27.63 Cytomegalovirus infection | 1 0.01 27.64 Decreased appetite | 4 0.04 27.68 Deep vein thrombosis | 10 0.10 27.78 Dehydration | 1 0.01 27.79 Delirium | 2 0.02 27.81 Dementia | 15 0.15 27.96 Dementia Alzheimer's type | 11 0.11 28.07 Depressed mood | 4 0.04 28.11 Depression | 104 1.04 29.15 Depression suicidal | 1 0.01 29.16 Dermatitis | 1 0.01 29.17 Dermatitis allergic | 1 0.01 29.18 Dermatomyositis | 5 0.05 29.23 Dermatophytosis of nail | 1 0.01 29.24 Diabetes mellitus | 106 1.06 30.30 Diabetic eye disease | 11 0.11 30.41 Diabetic ketoacidosis | 1 0.01 30.42 Diabetic nephropathy | 1 0.01 30.43 Diabetic neuropathy | 4 0.04 30.47 Diabetic retinal oedema | 25 0.25 30.72 Diabetic retinopathy | 16 0.16 30.88 Diagnostic procedure | 1 0.01 30.89 Diarrhoea | 12 0.12 31.01 Diffuse large B-cell lymphoma | 61 0.61 31.62 Diuretic therapy | 9 0.09 31.71 Dizziness | 5 0.05 31.76 Drug abuse | 11 0.11 31.87 Drug dependence | 6 0.06 31.93 Drug effect decreased | 1 0.01 31.94 Drug therapy | 4 0.04 31.98 Drug toxicity prophylaxis | 6 0.06 32.04 Drug withdrawal maintenance therapy | 3 0.03 32.07 Dry eye | 1 0.01 32.08 Dry mouth | 1 0.01 32.09 Dry skin | 1 0.01 32.10 Dumping syndrome | 1 0.01 32.11 Duodenal ulcer | 7 0.07 32.18 Dysbacteriosis | 1 0.01 32.19 Dyslipidaemia | 13 0.13 32.32 Dyspepsia | 30 0.30 32.62 Dysphagia | 6 0.06 32.68 Dyspnoea | 37 0.37 33.05 Dysuria | 1 0.01 33.06 Ear infection | 1 0.01 33.07 Ear pain | 2 0.02 33.09 Ectopic pregnancy termination | 1 0.01 33.10 Eczema | 1 0.01 33.11 Electrolyte imbalance | 1 0.01 33.12 Electrolyte substitution therapy | 2 0.02 33.14 Embolism | 2 0.02 33.16 Embolism arterial | 1 0.01 33.17 Embolism venous | 2 0.02 33.19 Emphysema | 16 0.16 33.35 Encephalopathy | 1 0.01 33.36 Endocarditis | 4 0.04 33.40 Endocarditis staphylococcal | 2 0.02 33.42 Endometrial cancer | 1 0.01 33.43 Endometriosis | 1 0.01 33.44 Enterocolitis | 1 0.01 33.45 Enterocolitis haemorrhagic | 10 0.10 33.55 Eosinophilic pneumonia | 2 0.02 33.57 Epidural anaesthesia | 4 0.04 33.61 Epidural test dose | 2 0.02 33.63 Epigastric discomfort | 2 0.02 33.65 Epilepsy | 24 0.24 33.89 Erectile dysfunction | 4 0.04 33.93 Erosive oesophagitis | 4 0.04 33.97 Erysipelas | 1 0.01 33.98 Erythema | 4 0.04 34.02 Escherichia test positive | 1 0.01 34.03 Escherichia urinary tract infection | 1 0.01 34.04 Essential hypertension | 5 0.05 34.09 Evacuation of retained products of co.. | 1 0.01 34.10 Ex-tobacco user | 1 0.01 34.11 Exposure during pregnancy | 2 0.02 34.13 Extrasystoles | 1 0.01 34.14 Eye disorder | 6 0.06 34.20 Eye swelling | 2 0.02 34.22 Fabry's disease | 2 0.02 34.24 Factor VIII deficiency | 2 0.02 34.26 Faeces hard | 1 0.01 34.27 Failure to thrive | 1 0.01 34.28 Fallopian tube cancer | 2 0.02 34.30 Fatigue | 2 0.02 34.32 Febrile neutropenia | 1 0.01 34.33 Feeling of relaxation | 1 0.01 34.34 Fibromyalgia | 42 0.42 34.76 Filariasis lymphatic | 2 0.02 34.78 Fluid replacement | 2 0.02 34.80 Fluid retention | 6 0.06 34.86 Foetal death | 2 0.02 34.88 Foetal exposure during pregnancy | 18 0.18 35.06 Foetal growth restriction | 1 0.01 35.07 Folate deficiency | 1 0.01 35.08 Fracture | 1 0.01 35.09 Functional gastrointestinal disorder | 1 0.01 35.10 Fungal infection | 5 0.05 35.15 Gallbladder cancer | 1 0.01 35.16 Gallbladder disorder | 4 0.04 35.20 Ganglioglioma | 1 0.01 35.21 Gastric cancer | 6 0.06 35.27 Gastric disorder | 11 0.11 35.38 Gastric infection | 2 0.02 35.40 Gastric mucosal lesion | 1 0.01 35.41 Gastric pH decreased | 1 0.01 35.42 Gastric ulcer | 6 0.06 35.48 Gastritis | 25 0.25 35.73 Gastritis erosive | 1 0.01 35.74 Gastritis prophylaxis | 10 0.10 35.84 Gastroenteritis | 7 0.07 35.91 Gastrointestinal cancer metastatic | 1 0.01 35.92 Gastrointestinal disorder | 1 0.01 35.93 Gastrointestinal disorder therapy | 3 0.03 35.96 Gastrointestinal haemorrhage | 2 0.02 35.98 Gastrointestinal motility disorder | 2 0.02 36.00 Gastrointestinal stromal tumour | 1 0.01 36.01 Gastrooesophageal reflux disease | 180 1.80 37.81 Gastrooesophageal reflux prophylaxis | 2 0.02 37.83 Generalised tonic-clonic seizure | 3 0.03 37.86 Genital herpes | 1 0.01 37.87 Gigantism | 1 0.01 37.88 Glaucoma | 12 0.12 38.00 Glioblastoma | 26 0.26 38.26 Goitre | 1 0.01 38.27 Gout | 13 0.13 38.40 Granulomatosis with polyangiitis | 4 0.04 38.44 Grief reaction | 2 0.02 38.46 Groin abscess | 1 0.01 38.47 Growth hormone deficiency | 5 0.05 38.52 Growth retardation | 3 0.03 38.55 HER-2 positive breast cancer | 10 0.10 38.65 HER-2 positive gastric cancer | 9 0.09 38.74 HIV infection | 36 0.36 39.10 Haemochromatosis | 1 0.01 39.11 Haemodialysis | 2 0.02 39.13 Haemolysis | 1 0.01 39.14 Haemolytic anaemia | 1 0.01 39.15 Haemolytic uraemic syndrome | 8 0.08 39.23 Haemorrhage subcutaneous | 1 0.01 39.24 Haemorrhoids | 1 0.01 39.25 Hair disorder | 1 0.01 39.26 Hallucination | 6 0.06 39.32 Head and neck cancer metastatic | 3 0.03 39.35 Headache | 34 0.34 39.69 Heart rate increased | 1 0.01 39.70 Heart rate irregular | 1 0.01 39.71 Heart transplant | 16 0.16 39.87 Heart transplant rejection | 1 0.01 39.88 Hepatic cancer | 2 0.02 39.90 Hepatic cirrhosis | 3 0.03 39.93 Hepatic steatosis | 1 0.01 39.94 Hepatitis | 1 0.01 39.95 Hepatitis B | 1 0.01 39.96 Hepatitis C | 47 0.47 40.43 Hepatitis cholestatic | 1 0.01 40.44 Hepato-lenticular degeneration | 1 0.01 40.45 Hepatocellular carcinoma | 1 0.01 40.46 Hereditary motor and sensory neuropathy | 1 0.01 40.47 Hereditary retinal dystrophy | 1 0.01 40.48 Herpes zoster | 6 0.06 40.54 Herpes zoster oticus | 1 0.01 40.55 Hiatus hernia | 15 0.15 40.70 Hiccups | 7 0.07 40.77 High density lipoprotein decreased | 3 0.03 40.80 Hip arthroplasty | 1 0.01 40.81 Hormone level abnormal | 1 0.01 40.82 Hormone replacement therapy | 7 0.07 40.89 Hormone therapy | 1 0.01 40.90 Hot flush | 4 0.04 40.94 House dust allergy | 1 0.01 40.95 Hypercalcaemia | 1 0.01 40.96 Hyperchlorhydria | 3 0.03 40.99 Hypercholesterolaemia | 18 0.18 41.17 Hyperglycaemia | 3 0.03 41.20 Hyperlipidaemia | 23 0.23 41.43 Hyperparathyroidism | 1 0.01 41.44 Hyperpituitarism | 1 0.01 41.45 Hypersensitivity | 38 0.38 41.83 Hypertension | 291 2.91 44.74 Hyperthyroidism | 8 0.08 44.82 Hypertonia | 2 0.02 44.84 Hypertonic bladder | 2 0.02 44.86 Hyperuricaemia | 11 0.11 44.97 Hypoalbuminaemia | 3 0.03 45.00 Hypogammaglobulinaemia | 2 0.02 45.02 Hypoglycaemia | 3 0.03 45.05 Hypokalaemia | 7 0.07 45.12 Hypomagnesaemia | 1 0.01 45.13 Hypoparathyroidism | 1 0.01 45.14 Hypophosphataemia | 2 0.02 45.16 Hypopituitarism | 2 0.02 45.18 Hypotension | 2 0.02 45.20 Hypothyroidism | 32 0.32 45.52 Hypovitaminosis | 4 0.04 45.56 Hysterectomy | 2 0.02 45.58 Idiopathic urticaria | 1 0.01 45.59 Ill-defined disorder | 3 0.03 45.62 Immune thrombocytopenic purpura | 11 0.11 45.73 Immunisation | 1 0.01 45.74 Immunoglobulin therapy | 1 0.01 45.75 Immunosuppressant drug therapy | 14 0.14 45.89 Immunosuppression | 7 0.07 45.96 Impaired gastric emptying | 1 0.01 45.97 Incontinence | 1 0.01 45.98 Increased appetite | 1 0.01 45.99 Induction and maintenance of anaesthe.. | 1 0.01 46.00 Induction of anaesthesia | 4 0.04 46.04 Infection | 15 0.15 46.19 Infection prophylaxis | 28 0.28 46.47 Inflammation | 3 0.03 46.50 Inflammatory bowel disease | 12 0.12 46.62 Influenza | 3 0.03 46.65 Influenza like illness | 1 0.01 46.66 Infusion related reaction | 2 0.02 46.68 Insomnia | 24 0.24 46.92 Intentional product misuse | 1 0.01 46.93 Interstitial lung disease | 3 0.03 46.96 Intervertebral disc degeneration | 2 0.02 46.98 Intervertebral disc protrusion | 2 0.02 47.00 Intraocular pressure increased | 2 0.02 47.02 Intraocular pressure test | 1 0.01 47.03 Invasive breast carcinoma | 3 0.03 47.06 Invasive ductal breast carcinoma | 2 0.02 47.08 Iron deficiency | 2 0.02 47.10 Iron deficiency anaemia | 4 0.04 47.14 Iron overload | 6 0.06 47.20 Irritable bowel syndrome | 1 0.01 47.21 Ischaemic heart disease prophylaxis | 2 0.02 47.23 Ischaemic stroke | 2 0.02 47.25 Joint stiffness | 1 0.01 47.26 Joint swelling | 1 0.01 47.27 Jugular vein thrombosis | 1 0.01 47.28 Juvenile idiopathic arthritis | 10 0.10 47.38 Kaposi's sarcoma AIDS related | 9 0.09 47.47 Keratitis | 2 0.02 47.49 Knee operation | 1 0.01 47.50 Lactation inhibition therapy | 1 0.01 47.51 Lacunar infarction | 1 0.01 47.52 Laxative supportive care | 3 0.03 47.55 Left ventricular dysfunction | 1 0.01 47.56 Limb discomfort | 1 0.01 47.57 Liver disorder | 3 0.03 47.60 Liver transplant | 8 0.08 47.68 Liver transplant rejection | 3 0.03 47.71 Local anaesthesia | 1 0.01 47.72 Lower limb fracture | 1 0.01 47.73 Lower respiratory tract infection | 3 0.03 47.76 Lung adenocarcinoma | 3 0.03 47.79 Lung cancer metastatic | 1 0.01 47.80 Lung carcinoma cell type unspecified .. | 1 0.01 47.81 Lung disorder | 5 0.05 47.86 Lung neoplasm malignant | 10 0.10 47.96 Lung transplant | 4 0.04 48.00 Lupus nephritis | 14 0.14 48.14 Lymphocytic lymphoma | 2 0.02 48.16 Lymphoedema | 2 0.02 48.18 Lymphoma | 7 0.07 48.25 Macular cyst | 1 0.01 48.26 Macular degeneration | 9 0.09 48.35 Macular ischaemia | 1 0.01 48.36 Macular oedema | 5 0.05 48.41 Maculopathy | 1 0.01 48.42 Maintenance of anaesthesia | 2 0.02 48.44 Major depression | 10 0.10 48.54 Malaria prophylaxis | 1 0.01 48.55 Malignant melanoma | 9 0.09 48.64 Malignant oligodendroglioma | 1 0.01 48.65 Malignant peritoneal neoplasm | 2 0.02 48.67 Malignant urinary tract neoplasm | 2 0.02 48.69 Mantle cell lymphoma | 8 0.08 48.77 Menopausal symptoms | 1 0.01 48.78 Menopause | 2 0.02 48.80 Menstrual cycle management | 1 0.01 48.81 Mental disorder | 10 0.10 48.91 Metabolic acidosis | 1 0.01 48.92 Metastases to bone | 4 0.04 48.96 Metastases to bone marrow | 2 0.02 48.98 Metastases to central nervous system | 1 0.01 48.99 Metastases to liver | 3 0.03 49.02 Metastases to lung | 2 0.02 49.04 Metastases to lymph nodes | 2 0.02 49.06 Metastases to nervous system | 2 0.02 49.08 Metastasis | 1 0.01 49.09 Metastatic malignant melanoma | 6 0.06 49.15 Metastatic renal cell carcinoma | 7 0.07 49.22 Micturition urgency | 1 0.01 49.23 Migraine | 36 0.36 49.59 Migraine with aura | 5 0.05 49.64 Mineral supplementation | 6 0.06 49.70 Mixed connective tissue disease | 6 0.06 49.76 Mood altered | 1 0.01 49.77 Mouth haemorrhage | 2 0.02 49.79 Movement disorder | 1 0.01 49.80 Mucopolysaccharidosis II | 3 0.03 49.83 Mucosal dryness | 1 0.01 49.84 Multiple allergies | 9 0.09 49.93 Multiple drug therapy | 6 0.06 49.99 Multiple sclerosis | 101 1.01 51.00 Multiple sclerosis relapse | 1 0.01 51.01 Muscle disorder | 1 0.01 51.02 Muscle relaxant therapy | 2 0.02 51.04 Muscle spasms | 15 0.15 51.19 Muscle spasticity | 2 0.02 51.21 Musculoskeletal discomfort | 1 0.01 51.22 Musculoskeletal pain | 2 0.02 51.24 Myalgia | 3 0.03 51.27 Myasthenia gravis | 1 0.01 51.28 Mycobacterium abscessus infection | 3 0.03 51.31 Mycosis fungoides | 6 0.06 51.37 Mycotic allergy | 1 0.01 51.38 Myelodysplastic syndrome | 17 0.17 51.55 Myelofibrosis | 1 0.01 51.56 Myeloproliferative neoplasm | 2 0.02 51.58 Myocardial infarction | 23 0.23 51.81 Myocardial ischaemia | 12 0.12 51.93 Myositis | 1 0.01 51.94 Narcolepsy | 1 0.01 51.95 Nasal congestion | 2 0.02 51.97 Nasal dryness | 1 0.01 51.98 Nasal polyps | 1 0.01 51.99 Nasopharyngitis | 11 0.11 52.10 Nausea | 47 0.47 52.57 Neck injury | 1 0.01 52.58 Neck pain | 2 0.02 52.60 Neoplasm malignant | 4 0.04 52.64 Neovascular age-related macular degen.. | 73 0.73 53.37 Nephritis | 1 0.01 53.38 Nephrogenic anaemia | 11 0.11 53.49 Nerve injury | 2 0.02 53.51 Nervous system disorder | 2 0.02 53.53 Nervousness | 8 0.08 53.61 Neuralgia | 22 0.22 53.83 Neuroendocrine carcinoma | 1 0.01 53.84 Neuroendocrine carcinoma metastatic | 1 0.01 53.85 Neuroendocrine tumour | 7 0.07 53.92 Neuromyelitis optica spectrum disorder | 2 0.02 53.94 Neuropathy peripheral | 15 0.15 54.09 Neutropenia | 2 0.02 54.11 Niemann-Pick disease | 2 0.02 54.13 Night sweats | 1 0.01 54.14 Non-Hodgkin's lymphoma | 14 0.14 54.28 Non-Hodgkin's lymphoma unspecified hi.. | 2 0.02 54.30 Non-small cell lung cancer | 14 0.14 54.44 Non-small cell lung cancer stage IV | 1 0.01 54.45 Nutritional supplementation | 7 0.07 54.52 Obsessive-compulsive disorder | 30 0.30 54.82 Obsessive-compulsive symptom | 3 0.03 54.85 Obstruction gastric | 1 0.01 54.86 Obstructive airways disorder | 4 0.04 54.90 Oedema | 6 0.06 54.96 Oedema peripheral | 5 0.05 55.01 Oesophageal carcinoma | 4 0.04 55.05 Oesophageal disorder | 2 0.02 55.07 Oesophageal rupture | 2 0.02 55.09 Oesophageal spasm | 1 0.01 55.10 Oesophageal ulcer | 7 0.07 55.17 Oesophagogastroduodenoscopy | 3 0.03 55.20 Oestrogen deficiency | 1 0.01 55.21 Oestrogen replacement therapy | 2 0.02 55.23 Off label use | 8 0.08 55.31 Optic neuritis | 2 0.02 55.33 Oral herpes | 2 0.02 55.35 Oral pain | 1 0.01 55.36 Organ transplant | 1 0.01 55.37 Oropharyngeal pain | 2 0.02 55.39 Osteoarthritis | 4 0.04 55.43 Osteogenesis imperfecta | 1 0.01 55.44 Osteonecrosis | 1 0.01 55.45 Osteopenia | 27 0.27 55.72 Osteoporosis | 129 1.29 57.01 Osteoporosis postmenopausal | 4 0.04 57.05 Osteoporosis prophylaxis | 17 0.17 57.22 Osteoporotic fracture | 4 0.04 57.26 Osteosarcoma | 2 0.02 57.28 Ovarian cancer | 15 0.15 57.43 Ovarian cyst | 1 0.01 57.44 Ovarian epithelial cancer | 3 0.03 57.47 Ovulation induction | 1 0.01 57.48 Pain | 155 1.55 59.03 Pain in extremity | 6 0.06 59.09 Pain management | 2 0.02 59.11 Pain prophylaxis | 2 0.02 59.13 Palmar-plantar erythrodysaesthesia sy.. | 5 0.05 59.18 Palpitations | 3 0.03 59.21 Pancreatic carcinoma | 6 0.06 59.27 Pancreatic carcinoma recurrent | 1 0.01 59.28 Pancreatic neuroendocrine tumour | 4 0.04 59.32 Pancreatitis acute | 4 0.04 59.36 Panic attack | 4 0.04 59.40 Panic disorder | 1 0.01 59.41 Paraesthesia | 1 0.01 59.42 Paraproteinaemia | 1 0.01 59.43 Parkinson's disease | 8 0.08 59.51 Paroxysmal nocturnal haemoglobinuria | 3 0.03 59.54 Pathologic myopia | 1 0.01 59.55 Pelvic abscess | 4 0.04 59.59 Pelvic pain | 2 0.02 59.61 Pemphigoid | 2 0.02 59.63 Pemphigus | 4 0.04 59.67 Peptic ulcer | 5 0.05 59.72 Percutaneous coronary intervention | 3 0.03 59.75 Peripheral arterial occlusive disease | 3 0.03 59.78 Peripheral swelling | 1 0.01 59.79 Peripheral venous disease | 1 0.01 59.80 Peritoneal dialysis | 8 0.08 59.88 Peritoneal tuberculosis | 3 0.03 59.91 Pernicious anaemia | 1 0.01 59.92 Persistent foetal circulation | 1 0.01 59.93 Pharyngeal lesion | 2 0.02 59.95 Pharyngeal oedema | 1 0.01 59.96 Phlebitis | 2 0.02 59.98 Pituitary tumour | 2 0.02 60.00 Pituitary tumour removal | 1 0.01 60.01 Pituitary-dependent Cushing's syndrome | 1 0.01 60.02 Plasma cell myeloma | 115 1.15 61.17 Platelet count increased | 1 0.01 61.18 Pneumocystis jirovecii pneumonia | 1 0.01 61.19 Pneumonia | 5 0.05 61.24 Pneumonitis | 1 0.01 61.25 Poisoning | 7 0.07 61.32 Pollakiuria | 7 0.07 61.39 Polycythaemia vera | 1 0.01 61.40 Polymyalgia rheumatica | 1 0.01 61.41 Polymyositis | 2 0.02 61.43 Polyneuropathy | 4 0.04 61.47 Poor peripheral circulation | 1 0.01 61.48 Post coital contraception | 1 0.01 61.49 Post concussion syndrome | 2 0.02 61.51 Post herpetic neuralgia | 1 0.01 61.52 Post procedural pneumonia | 1 0.01 61.53 Post-traumatic neck syndrome | 1 0.01 61.54 Post-traumatic stress disorder | 8 0.08 61.62 Postmenopause | 1 0.01 61.63 Postoperative analgesia | 1 0.01 61.64 Postpartum depression | 1 0.01 61.65 Postresuscitation encephalopathy | 1 0.01 61.66 Pregnancy | 1 0.01 61.67 Premature ejaculation | 1 0.01 61.68 Premedication | 128 1.28 62.96 Premenstrual syndrome | 2 0.02 62.98 Procedural pain | 2 0.02 63.00 Proctitis | 1 0.01 63.01 Product use issue | 2 0.02 63.03 Product used for unknown indication | 1,827 18.27 81.30 Productive cough | 2 0.02 81.32 Prolactinoma | 1 0.01 81.33 Prophylaxis | 186 1.86 83.19 Prophylaxis against HIV infection | 5 0.05 83.24 Prophylaxis against alcoholic withdra.. | 1 0.01 83.25 Prophylaxis against diarrhoea | 1 0.01 83.26 Prophylaxis against gastrointestinal .. | 20 0.20 83.46 Prophylaxis against graft versus host.. | 10 0.10 83.56 Prophylaxis against transplant reject.. | 16 0.16 83.72 Prophylaxis of nausea and vomiting | 5 0.05 83.77 Prostate cancer | 11 0.11 83.88 Prostate cancer metastatic | 4 0.04 83.92 Prostatic disorder | 4 0.04 83.96 Prostatic specific antigen increased | 2 0.02 83.98 Prostatism | 1 0.01 83.99 Prostatitis | 2 0.02 84.01 Prostatomegaly | 13 0.13 84.14 Protein urine present | 1 0.01 84.15 Proteinuria | 1 0.01 84.16 Prothrombin level decreased | 1 0.01 84.17 Pruritus | 8 0.08 84.25 Pseudomembranous colitis | 1 0.01 84.26 Pseudomonas infection | 1 0.01 84.27 Psoriasis | 132 1.32 85.59 Psoriatic arthropathy | 60 0.60 86.19 Psychiatric symptom | 3 0.03 86.22 Psychological abuse | 2 0.02 86.24 Psychotic disorder | 17 0.17 86.41 Pulmonary arterial hypertension | 40 0.40 86.81 Pulmonary calcification | 2 0.02 86.83 Pulmonary embolism | 7 0.07 86.90 Pulmonary fibrosis | 3 0.03 86.93 Pulmonary hypertension | 15 0.15 87.08 Pulmonary mycosis | 1 0.01 87.09 Pustular psoriasis | 2 0.02 87.11 Pyrexia | 16 0.16 87.27 Quality of life decreased | 1 0.01 87.28 Rash | 8 0.08 87.36 Reactive airways dysfunction syndrome | 2 0.02 87.38 Rectal cancer | 11 0.11 87.49 Red blood cell count abnormal | 1 0.01 87.50 Refractory anaemia with an excess of .. | 1 0.01 87.51 Relapsing-remitting multiple sclerosis | 12 0.12 87.63 Relaxation therapy | 2 0.02 87.65 Renal cancer | 4 0.04 87.69 Renal cancer metastatic | 1 0.01 87.70 Renal cancer stage IV | 1 0.01 87.71 Renal cell carcinoma | 11 0.11 87.82 Renal disorder | 3 0.03 87.85 Renal failure | 5 0.05 87.90 Renal neoplasm | 1 0.01 87.91 Renal transplant | 29 0.29 88.20 Respiratory disorder | 4 0.04 88.24 Respiratory failure | 1 0.01 88.25 Restless legs syndrome | 7 0.07 88.32 Restlessness | 1 0.01 88.33 Restrictive cardiomyopathy | 2 0.02 88.35 Restrictive pulmonary disease | 1 0.01 88.36 Retained products of conception | 1 0.01 88.37 Retinal artery occlusion | 1 0.01 88.38 Retinal degeneration | 1 0.01 88.39 Retinal detachment | 1 0.01 88.40 Retinal disorder | 1 0.01 88.41 Retinal haemorrhage | 2 0.02 88.43 Retinal neovascularisation | 1 0.01 88.44 Retinal oedema | 12 0.12 88.56 Retinal vein occlusion | 21 0.21 88.77 Retinopathy | 1 0.01 88.78 Rheumatic disorder | 1 0.01 88.79 Rheumatoid arthritis | 354 3.54 92.33 Rheumatoid vasculitis | 1 0.01 92.34 Rhinitis | 4 0.04 92.38 Rhinitis allergic | 9 0.09 92.47 Right ventricular failure | 1 0.01 92.48 Rosacea | 2 0.02 92.50 Routine health maintenance | 10 0.10 92.60 Salivary hypersecretion | 1 0.01 92.61 Sarcoma | 5 0.05 92.66 Scar | 2 0.02 92.68 Schizoaffective disorder | 5 0.05 92.73 Schizophrenia | 65 0.65 93.38 Schizophreniform disorder | 6 0.06 93.44 Sciatica | 4 0.04 93.48 Seasonal affective disorder | 1 0.01 93.49 Seasonal allergy | 4 0.04 93.53 Seborrhoeic dermatitis | 2 0.02 93.55 Secondary adrenocortical insufficiency | 1 0.01 93.56 Secondary progressive multiple sclero.. | 3 0.03 93.59 Sedation | 7 0.07 93.66 Sedative therapy | 3 0.03 93.69 Seizure | 21 0.21 93.90 Sepsis | 1 0.01 93.91 Short-bowel syndrome | 1 0.01 93.92 Sickle cell anaemia | 2 0.02 93.94 Sinus arrhythmia | 1 0.01 93.95 Sinus congestion | 1 0.01 93.96 Sinus disorder | 1 0.01 93.97 Sinusitis | 4 0.04 94.01 Sjogren's syndrome | 2 0.02 94.03 Skeletal injury | 1 0.01 94.04 Skin infection | 3 0.03 94.07 Skin irritation | 1 0.01 94.08 Skin ulcer | 7 0.07 94.15 Sleep disorder | 31 0.31 94.46 Small for dates baby | 1 0.01 94.47 Smoking cessation therapy | 5 0.05 94.52 Spinal column stenosis | 2 0.02 94.54 Spinal compression fracture | 1 0.01 94.55 Spinal cord disorder | 1 0.01 94.56 Spinal cord herniation | 1 0.01 94.57 Spinal disorder | 1 0.01 94.58 Spinal osteoarthritis | 1 0.01 94.59 Spinal pain | 1 0.01 94.60 Spondyloarthropathy | 1 0.01 94.61 Squamous cell carcinoma | 4 0.04 94.65 Squamous cell carcinoma of skin | 1 0.01 94.66 Staphylococcal infection | 15 0.15 94.81 Status epilepticus | 1 0.01 94.82 Stem cell transplant | 2 0.02 94.84 Stent malfunction | 1 0.01 94.85 Stent placement | 17 0.17 95.02 Stevens-Johnson syndrome | 5 0.05 95.07 Still's disease adult onset | 25 0.25 95.32 Stomatitis | 7 0.07 95.39 Streptococcal infection | 1 0.01 95.40 Stress | 3 0.03 95.43 Stress ulcer | 1 0.01 95.44 Stress urinary incontinence | 1 0.01 95.45 Subcutaneous abscess | 4 0.04 95.49 Substance abuse | 3 0.03 95.52 Suicide attempt | 3 0.03 95.55 Supplementation therapy | 20 0.20 95.75 Supraventricular tachycardia | 4 0.04 95.79 Surgery | 2 0.02 95.81 Swelling | 5 0.05 95.86 Systemic candida | 1 0.01 95.87 Systemic lupus erythematosus | 17 0.17 96.04 Systemic sclerosis | 2 0.02 96.06 Tachyarrhythmia | 2 0.02 96.08 Tardive dyskinesia | 1 0.01 96.09 Tendon rupture | 1 0.01 96.10 Thromboangiitis obliterans | 1 0.01 96.11 Thrombocytopenia | 2 0.02 96.13 Thrombophlebitis superficial | 2 0.02 96.15 Thrombosis | 11 0.11 96.26 Thrombosis prophylaxis | 43 0.43 96.69 Thyroid cancer | 8 0.08 96.77 Thyroid disorder | 28 0.28 97.05 Thyroidectomy | 1 0.01 97.06 Tocolysis | 1 0.01 97.07 Tonsil cancer | 2 0.02 97.09 Tooth abscess | 1 0.01 97.10 Tooth infection | 2 0.02 97.12 Toothache | 4 0.04 97.16 Transient ischaemic attack | 3 0.03 97.19 Transplant rejection | 1 0.01 97.20 Tremor | 2 0.02 97.22 Trigeminal nerve disorder | 1 0.01 97.23 Trigeminal neuralgia | 3 0.03 97.26 Tuberculosis | 5 0.05 97.31 Tuberous sclerosis | 1 0.01 97.32 Tumour lysis syndrome | 1 0.01 97.33 Turner's syndrome | 1 0.01 97.34 Type 1 diabetes mellitus | 10 0.10 97.44 Type 2 diabetes mellitus | 94 0.94 98.38 Ulcer | 15 0.15 98.53 Undifferentiated sarcoma | 4 0.04 98.57 Upper respiratory tract infection | 4 0.04 98.61 Upper respiratory tract inflammation | 6 0.06 98.67 Urinary incontinence | 2 0.02 98.69 Urinary retention | 1 0.01 98.70 Urinary tract infection | 8 0.08 98.78 Urinary tract pain | 1 0.01 98.79 Urine analysis abnormal | 1 0.01 98.80 Urticaria | 4 0.04 98.84 Uterine haemorrhage | 3 0.03 98.87 Uveitis | 4 0.04 98.91 Vaginal haemorrhage | 1 0.01 98.92 Vaginal inflammation | 1 0.01 98.93 Varices oesophageal | 2 0.02 98.95 Vascular graft | 1 0.01 98.96 Vasculitis | 5 0.05 99.01 Vasculitis cerebral | 4 0.04 99.05 Vasodilatation | 1 0.01 99.06 Vasomotor rhinitis | 3 0.03 99.09 Vasospasm | 2 0.02 99.11 Vein disorder | 1 0.01 99.12 Venous occlusion | 4 0.04 99.16 Venous thrombosis | 1 0.01 99.17 Ventricular arrhythmia | 1 0.01 99.18 Ventricular fibrillation | 1 0.01 99.19 Ventricular tachycardia | 2 0.02 99.21 Vertigo | 1 0.01 99.22 Vertigo positional | 1 0.01 99.23 Victim of child abuse | 1 0.01 99.24 Victim of crime | 2 0.02 99.26 Victim of sexual abuse | 1 0.01 99.27 Viral infection | 1 0.01 99.28 Vitamin B12 deficiency | 1 0.01 99.29 Vitamin D decreased | 2 0.02 99.31 Vitamin D deficiency | 4 0.04 99.35 Vitamin supplementation | 12 0.12 99.47 Vitreous detachment | 1 0.01 99.48 Vitreous haemorrhage | 2 0.02 99.50 Vomiting | 17 0.17 99.67 Vulvovaginal dryness | 2 0.02 99.69 Vulvovaginal pain | 2 0.02 99.71 Waldenstrom's macroglobulinaemia | 8 0.08 99.79 Weight loss diet | 1 0.01 99.80 Wheezing | 15 0.15 99.95 Wound infection pseudomonas | 3 0.03 99.98 Zinc deficiency | 2 0.02 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 6 Apr 2017